Pharmaceutical Industry

Drug Development Research and Development Drug Manufacturing Drug Pricing Manufacturing Production Vaccine Development Clinical Trials Prescription Drugs Innovation

Lilly Strikes $2.75 Billion Deal to Commercialize Insilico’s AI-Designed Drugs

The pact signals big pharma’s push to tap outside AI tools for faster pipelines.

Law Firms Urge Inovio Investors to Seek Lead Role in Securities Case

Roche Expands NVIDIA Partnership, Building Pharma’s Largest Hybrid‑Cloud AI Factory

Astellas–Vir Prostate Cancer Alliance Launches With New Data as VIR Stock Surges

Takeda Strikes Multi-Year AI Drug Discovery Pact With Iambic Worth Over $1.7 Billion

AstraZeneca Pledges $15 Billion China Expansion Through 2030

Anticorruption Secretariat Bars Three Suppliers Over Bidding Irregularities

India's Pharma Exports Top $30 Billion as Government Targets Regulatory Hurdles

Sanofi, Dren Bio Set Autoimmune Collaboration Worth Up to $1.7 Billion With $100 Million Upfront

HSBC Upgrades AbbVie to Buy, Lifts Target to $265 as Skyrizi and Rinvoq Drive Growth

India Pharma Charts Shift From Generics to Biologics at CPHI & PMEC India

Novartis Picks North Carolina for Flagship End-to-End Drug Manufacturing Hub

Lilly and Nvidia Unveil Pharma-Scale AI Factory Built on DGX SuperPOD

Takeda and Nabla Bio Expand AI Protein-Design Deal With Potential Payouts Above $1 Billion

German Antitrust Watchdog Clears BioNTech’s CureVac Takeover

Querétaro Inaugurates What Officials Call Mexico’s First Green Hydrogen Plant

Takeda Ends In-House Cell Therapy Research, Seeks Partners for Assets

Pakistan Unveils Five-Year Push for $30 Billion in Pharma Exports

Anvisa Orders Recall of Hypofarma Furosemide Batch Over Glass-Like Material

India, UAE Advance CEPA Implementation, Set Near-Term Actions Toward $100 Billion Non‑Oil Trade